Mode
Text Size
Log in / Sign up

Liposomal bupivacaine, nerve blocks compared to lidocaine for skin graft donor site pain in burn patientsWhat's the best way to ease pain after skin graft surgery for burn patients?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: No efficacy or safety results reported from this trial comparing local anesthetics for donor site pain.

This two-phase study investigated postoperative pain management at split-thickness skin graft donor sites in burn patients. The first phase was a randomized controlled trial comparing injection of liposomal bupivacaine (Exparel) at harvest to injection of lidocaine with epinephrine. The second phase was a prospective cohort study using historic controls from the first phase, where patients received preoperative regional nerve blocks (fascia iliaca, lateral femoral cutaneous, or femoral) based on donor site location. The study enrolled 74 patients with less than 20% total body surface area (TBSA) burns and less than 5% deep partial or full-thickness wounds.

The primary outcome was postoperative pain at the donor site measured using a 0-10 Visual Analog Scale (VAS) at 8 hours postoperatively. No results for this primary outcome, or for any secondary outcomes, were reported in the provided data. The effect size, absolute numbers, and statistical significance for pain scores are unavailable.

Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, were not reported. The study had a notably long follow-up period of 76.6 months, though its relevance to the acute pain outcome is unclear. Key limitations include the lack of reported results and the use of historic controls in the second phase, which introduces potential confounding. Without efficacy or safety results, this study's practice relevance cannot be assessed. Clinicians should note that the evidence from this trial remains incomplete.

Imagine the pain of a serious burn, then needing surgery where doctors take healthy skin from another part of your body to help you heal. The spot where that skin is taken from—the donor site—can be incredibly painful after surgery. For burn patients with less than 20% of their body burned, doctors wanted to find a better way to manage that specific pain.

In a two-part study, researchers compared three approaches. First, they tested an injection of a long-acting numbing medicine (liposomal bupivacaine) against a standard numbing shot (lidocaine) right at the donor site. In the second part, they tried a different tactic: blocking the nerves that serve the donor area with regional anesthesia before surgery, and compared those results to the patients from the first part of the study.

The goal was to see which method best reduced pain and the need for opioid painkillers after surgery. However, the crucial results—the actual pain scores and medication use—haven't been reported yet. The study followed patients for over six years, but without the findings, we don't know if one method was safer or more effective. This leaves an important question unanswered for patients and surgeons looking for the most reliable way to control this difficult pain.

What this means for you:
Study tested pain control for skin graft sites, but results are not yet in.

Study Details

Study typePhase4
Sample sizen = 74
EvidenceLevel 2
Follow-up76.6 mo
PublishedMar 2026
View Original Abstract ↓
Status: COMPLETED | Phase: PHASE4 Condition(s): Pain, Postoperative, Burns Intervention(s): Lidocaine Hydrochloride (DRUG), Liposomal bupivacaine (DRUG), Bupivacaine Hydrochloride (DRUG) Donor site pain study comparing post-operative donor site pain and opioid consumption after use of Lidocaine, Liposomal Bupivicaine or regional nerve block for split thickness skin graft harvesting in patients with less than 20% TBSA burn wounds and less than %5 Deep partial or full thickness burn wounds. Detailed: The first phase of the study was a randomized controlled study. In the second phase, all subjects will receive fascia iliaca, lateral femoral cutaneous, or femoral nerve blocks based on the proposed donor site location and will be compared to historic controls from the first phase. In the first phase, the control group underwent split thickness autografting using the standard protocol, involving injection of lidocaine with epinephrine at the donor site. In the first phase, the experimental group underwent injection of liposomal bupivacaine (Exparel) at the time of harvest of the skin graft. In the second phase, patients will undergo preoperative regional anesthesia with a fascia iliaca, lateral femoral cutaneous, or femoral nerve block based on the proposed donor site location rather than Primary Outcome(s): A Measurement of Post Operative Pain Involving Skin Graft Donor Site Using Visual Analog Scale (VAS) Ranging 0-10, at 8 Hours Post-operatively Enrollment: 74 (ACTUAL) Lead Sponsor: University of Kansas Medical Center Start: 2019-03-18 | Primary Completion: 2025-08-06 Results posted: 2026-03-31
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.